Effect of risk warning on non­invasive ventilator treatment for pulmonary heart disease accompanied by respiratory failure

doi:10.3877/cma.j.issn.1674-6902.2024.04.029

Abstract

Juanjuan Liu, Zhihua Li. Effect of risk warning on noninvasive ventilator treatment for pulmonary heart disease accompanied by respiratory failure[J]. Chinese Journal of Lung Diseases(Electronic Edition), 2024, 17(04): 645-647.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhfbjbzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.1674-6902.2024.04.029

https://zhfbjbzz.cma-cmc.com.cn/EN/Y2024/V17/I04/645

Figures/Tables 3

References 26

1	Xiao M, Lai D, Yu Y, et al. Pathogenesis of pulmonary hypertension caused by left heart disease[J]. Front Cardiovasc Med, 2023, 10: 1079142.
2	You L, Niu H, Huang K, et al. Clinical features and outcomes of acute exacerbation in chronic obstructive pulmonary disease patients with pulmonary heart disease: a multicenter observational study[J]. Int J Chron Obstruct Pulmon Dis, 2021, 16: 2901-2910.
3	Khandait H, Harkut P, Khandait V, et al. Acute pulmonary embolism：Diagnosis and management[J]. Indian Heart J, 2023, 75(5): 335-342.
4	Bayes-genis A, Docherty KF, Petrie MC, et al. Practical algorithms for early diagnosis of heart failure and heart stress using NT-proBNP: A clinical consensus statement from the Heart Failure Association of the ESC[J]. Eur J Heart Fail, 2023, 25(11): 1891-1898.
5	Brodie D, Slutsky AS, Combes A. Extracorporeal life support for adults with respiratory failure and related indications: a review[J]. Jama, 2019, 322(6): 557-568.
6	Grieco DL, Menga LS, Eleuteri D, et al. Patient self-inflicted lung injury: implications for acute hypoxemic respiratory failure and ARDS patients on non-invasive support[J]. Minerva Anestesiol, 2019, 85(9): 1014-1023.
7	Dogan N, Özturan IU, Pekdemir M, et al. Prognostic value of early warning scores in patients presenting to the emergency department with exacerbation of COPD[J]. Med Klin Intensivmed Notfmed, 2024, 119(2): 129-135.
8	张玉叶，潘　英，周红娟. 心脏康复联合个性化护理对心肌梗死伴胃溃疡患者心理状态、症状及并发症的影响[J]. 现代中西医结合杂志，2023, 32(22): 3178-3181.
9	周　娟，杨　欢，姜　姗. 心理护理联合个性护理对慢性心力衰竭患者生活质量、自我防护意识的影响[J]. 中华养生保健，2024, 42(10): 118-121.
10	Germanova OA, Vukolova YY, Strelnik A, et al. Application of SF-36 health status survey in patients with arterial hypertension[J]. Psychiatr Danub, 2023, 35(Suppl 2): 318-321.
11	邵丽丽，施金梅，钱　霞，等. 激励式护理在RICU呼吸衰竭患者中的应用效果及对SAS、SDS评分的影响[J]. 名医，2023, (5): 128-130.
12	张叶斐，赵　洁，董春叶，等. 危重症专职小组气道综合护理对肺心病合并呼吸衰竭患者机械通气血气指标及肺功能的影响[J]. 医学信息，2023, 36(19): 163-166.
13	Urakov A, Urakova N, Gurevich K, et al. Cardiology, respiratory failure, and tolerance of hypoxia in the context of COVID-19: a multidisciplinary perspective[J]. Rev Cardiovasc Med, 2022, 23(1): 21.
14	Chen L, Rackley CR. Diagnosis and epidemiology of acute respiratory failure[J]. Crit Care Clin, 2024, 40(2): 221-233.
15	Macleod M, Papi A, Contoli M, et al. Chronic obstructive pulmonary disease exacerbation fundamentals: Diagnosis, treatment, prevention and disease impact[J]. Respirology, 2021, 26(6): 532-551.
16	Bello AR, Tralhão A. Non-invasive ventilation for cardiogenic shock associated respiratory failure-Striking the perfect balance between risk and benefit[J]. Rev Port Cardiol, 2024, 43(5): 275-277.
17	Chen X, Wu X. Assessment of non-invasive ventilation combined with naloxone for the management of acute respiratory failure in patients with chronic obstructive pulmonary disease[J]. Altern Ther Health Med, 2024, PMID：38430175.
18	Jimenez JV, Ackrivo J, Hsu JY, et al. Lowering P(CO(2)) with noninvasive ventilation is associated with improved survival in chronic hypercapnic respiratory failure[J]. Respir Care, 2023, 68(12): 1613-1622.
19	MASIP J. Noninvasive ventilation in acute heart failure[J]. Curr Heart Fail Rep, 2019, 16(4): 89-97.
20	Chawla R, Dixit SB, Zirpe KG, et al. ISCCM guidelines for the use of non-invasive ventilation in acute respiratory failure in adult ICUs[J]. Indian J Crit Care Med, 2020, 24(Suppl 1): S61-S81.
21	李雪峰. 慢性肺心病患者急性加重期的呼吸道护理干预效果分析[J]. 保健医学研究与实践，2015, 12(1): 74＋76.
22	李欣欣，何应丰，周亮亮，等. 经鼻高流量氧疗对ICU肺心病并发Ⅱ型呼吸衰竭的效果及凝血功能的影响[J]. 现代医药卫生，2022, 38(24): 4274-4276.
23	田仁义. 长期氧疗联合肺康复功能锻炼对慢阻肺并合肺心病的疗效分析[J]. 世界最新医学信息文摘，2019, 19(21): 73＋76.
24	王　城，阮　敏. 个体化护理干预在高通量血液透析治疗肺源性心脏病心力衰竭患者中的应用效果探讨[J]. 基层医学论坛，2018, 22(33): 4785-4786.
25	李君玲. 个体化护理措施对急性闭角型青光眼患者术后负性心理情绪、预后的影响研究[J]. 黑龙江医学，2023, 47(24): 3047-3049.
26	王海兄，刘　明，王婷婷. 个体化肺康复护理对慢性阻塞性肺疾病患者肺功能的影响[J]. 中西医结合护理(中英文), 2024, 10(3): 85-87.

组　别	例数	治疗前/后	社会功能	生理职能	情感职能	躯体疼痛	精神健康	总体健康	活　力
观察组	39	治疗前	54.21±5.83	57.33±6.51	52.96±5.41	55.46±6.32	55.43±5.84	54.63±5.52	52.93±5.56
		治疗后	74.82±6.64^b	81.42±7.13^b	78.93±6.93^b	80.32±7.11^b	81.35±7.42^b	81.34±6.91^b	79.92±7.04^b
对照组	31	治疗前	53.54±5.523	57.63±5.526	52.45±5.32	57.44±6.12	54.43±5.45	52.37±5.31	51.74±5.25
		治疗后	71.21±6.43^a	74.82±6.81^a	75.84±5.73^a	74.94±6.52^a	75.62±6.94^a	76.36±7.22^a	71.63±5.56^a

组　别	例数	治疗前/后	社会功能	生理职能	情感职能	躯体疼痛	精神健康	总体健康	活　力
观察组	39	治疗前	54.21±5.83	57.33±6.51	52.96±5.41	55.46±6.32	55.43±5.84	54.63±5.52	52.93±5.56
		治疗后	74.82±6.64^b	81.42±7.13^b	78.93±6.93^b	80.32±7.11^b	81.35±7.42^b	81.34±6.91^b	79.92±7.04^b
对照组	31	治疗前	53.54±5.523	57.63±5.526	52.45±5.32	57.44±6.12	54.43±5.45	52.37±5.31	51.74±5.25
		治疗后	71.21±6.43^a	74.82±6.81^a	75.84±5.73^a	74.94±6.52^a	75.62±6.94^a	76.36±7.22^a	71.63±5.56^a

组　别	例数	pH		PaO₂(mmHg)		PaCO₂(mmHg)		HCO₃^－(mmol/L)		SaO₂(%)
组　别	例数	治疗前	治疗后	治疗前	治疗后	治疗前	治疗后	治疗前	治疗后	治疗前	治疗后
观察组	39	7.44±0.06	7.45±0.07	58.71±13.54	85.75±12.86	57.22±15.43	52.55±9.72	33.53±6.72	28.73±5.86	77.81±18.52	91.76±16.27
对照组	31	7.37±0.04	7.42±0.03	62.57±12.36	79.24±13.17	49.88±12.14	47.94±8.61	31.70±5.75	27.80±4.37	83.52±16.24	82.56±15.19
t值		3.796	1.445	－1.231	2.082	－2.449	1.479	0.855	0.509	－1.352	2.419
P值		0.004	0.155	0.223	0.021	0.017	0.145	0.397	0.613	0.181	0.018

组　别	例数	pH		PaO₂(mmHg)		PaCO₂(mmHg)		HCO₃^－(mmol/L)		SaO₂(%)
组　别	例数	治疗前	治疗后	治疗前	治疗后	治疗前	治疗后	治疗前	治疗后	治疗前	治疗后
观察组	39	7.44±0.06	7.45±0.07	58.71±13.54	85.75±12.86	57.22±15.43	52.55±9.72	33.53±6.72	28.73±5.86	77.81±18.52	91.76±16.27
对照组	31	7.37±0.04	7.42±0.03	62.57±12.36	79.24±13.17	49.88±12.14	47.94±8.61	31.70±5.75	27.80±4.37	83.52±16.24	82.56±15.19
t值		3.796	1.445	－1.231	2.082	－2.449	1.479	0.855	0.509	－1.352	2.419
P值		0.004	0.155	0.223	0.021	0.017	0.145	0.397	0.613	0.181	0.018

组　别	例数	SAS评分		DS评分
组　别	例数	治疗前	治疗后	治疗前	治疗后
观察组	39	64.13±5.37	40.13±3.89	59.73±3.08	39.18±2.79
对照组	31	62.48±5.29	47.38±4.05	61.58±3.25	48.12±2.98
t值		1.548	9.129	2.922	15.486
P值		0.125	0.000	0.004	0.000

Please choose a citation manager

Content to export

Effect of risk warning on noninvasive ventilator treatment for pulmonary heart disease accompanied by respiratory failure

RichHTML

PDF (PC)

Knowledge

Cited

Abstract

Cite this article

share this article

Figures/Tables 3

References 26

Related Articles 0

Recommended Articles

Metrics

Comments

模态框（Modal）标题

Please choose a citation manager

Content to export

Effect of risk warning on non­invasive ventilator treatment for pulmonary heart disease accompanied by respiratory failure

RichHTML

PDF (PC)

Knowledge

Cited

Abstract

Cite this article

share this article

Figures/Tables 3

References 26

Related Articles 0

Recommended Articles

Metrics

Comments

Effect of risk warning on noninvasive ventilator treatment for pulmonary heart disease accompanied by respiratory failure